Abstract Introduction The United States experienced a substantial increase in reported
pertussis cases over the last decade. Since 2005, persons 11 years and older have been …

Abstract Background In the United States, persons≥ 11 years are recommended to receive
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …

Abstract Currently, the Advisory Committee on Immunization Practices recommends one-
time tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination for …

Despite sustained high coverage for childhood pertussis vaccination, pertussis remains
poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths …

Objectives Health benefits and costs of combined reduced-antigen-content tetanus,
diphtheria, and pertussis (Tdap) immunization among adults≥ 65 years have not been …

Objectives In February 2012, the Advisory Committee on Immunization Practices (ACIP)
advised that all adults aged≥ 65 years receive a single dose of reduced-antigen-content …

Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …

CLINICIANS SHOULD VACCINATE caregivers and household contacts of infants with the
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) even if the …